tiprankstipranks
Trending News
More News >
Biotest AG (DE:BIO3)
HAMBURG:BIO3
Germany Market
Advertisement

Biotest (BIO3) Stock Forecast & Price Target

Compare
2 Followers
See the Price Targets and Ratings of:

BIO3 Financial Forecast

No data currently available

BIO3 Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

BIO3 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:BIO3
TipRanks AITipRanks
Not Ranked
TipRanks
€30
Hold
1.35%
Upside
Reiterated
07/16/25
The overall stock score reflects stable financial performance with some risks due to declining profitability and high leverage. Technical indicators suggest neutral momentum, while valuation metrics indicate potential overvaluation. The absence of earnings call and corporate events data limits further insights.
AI Firm
€28€31
Hold
4.73%
Upside
Reiterated
06/14/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:BIO3
TipRanks AITipRanks
Not Ranked
TipRanks
€30
Hold
1.35%
Upside
Reiterated
07/16/25
The overall stock score reflects stable financial performance with some risks due to declining profitability and high leverage. Technical indicators suggest neutral momentum, while valuation metrics indicate potential overvaluation. The absence of earnings call and corporate events data limits further insights.
AI Firm
€28€31
Hold
4.73%
Upside
Reiterated
06/14/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

BIO3 Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

BIO3 Stock Forecast FAQ

What is DE:BIO3’s average 12-month price target, according to analysts?
Based on analyst ratings, Biotest AG’s 12-month average price target is 31.00.
    What is DE:BIO3’s upside potential, based on the analysts’ average price target?
    Biotest AG has 4.73% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Biotest AG a Buy, Sell or Hold?
          Biotest AG has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Biotest AG’s share price target?
            The average share price target for Biotest AG is 31.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €31.00 ,and the lowest forecast is €31.00. The average share price target represents 4.73% Increase from the current price of €29.6.
              What do analysts say about Biotest AG?
              Biotest AG’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Biotest AG?
                To buy shares of DE:BIO3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis